Esophageal dysmotility happens when the muscles of the esophagus don’t contract in the coordinated, wave-like pattern needed to push food from your throat to your stomach. The causes range from nerve damage and autoimmune processes to systemic diseases like scleroderma and diabetes. In many cases, the exact trigger is never identified, but understanding the categories of causes helps clarify what’s happening and what to expect.
How Normal Swallowing Works
When you swallow, a precisely timed sequence of muscle contractions travels down the esophagus, creating a wave called peristalsis. At the bottom, a ring of muscle called the lower esophageal sphincter relaxes to let food pass into the stomach, then closes again to prevent acid from flowing back up. This entire process depends on a network of nerve cells embedded in the esophageal wall, known as the myenteric plexus, coordinating both the squeezing and relaxing of muscles. When any part of this system breaks down, whether the nerves, the muscles, or the signals between them, you get dysmotility.
Nerve Cell Loss in Achalasia
Achalasia is the best-understood primary motility disorder, and its mechanism offers a window into how esophageal dysmotility develops at the cellular level. The core problem is a progressive loss of nerve cells (ganglion cells) within the myenteric plexus. These are the neurons responsible for telling the lower esophageal sphincter to relax and for coordinating the sequential contractions that move food downward. As these cells die off, the sphincter fails to open properly and peristalsis weakens or disappears entirely.
Examination of tissue from achalasia patients consistently shows fewer ganglion cells surrounded by clusters of inflammatory immune cells, a pattern that strongly suggests an autoimmune attack. The degree of nerve cell loss tracks with how long someone has had the disease, typically progressing from mild outflow obstruction to complete loss of peristalsis in advanced stages. The leading theory is that the immune system attacks these neurons in genetically susceptible people, possibly triggered by a viral infection. Herpes simplex virus type 1 has been proposed as one potential trigger.
Globally, achalasia affects roughly 11 people per 100,000, with an incidence of about 0.8 new cases per 100,000 each year. It’s far more common in adults than children (about 15 per 100,000 versus less than 1 per 100,000). Reported incidence has been rising over the past century, likely due to better diagnostic tools rather than a true increase in the disease itself.
Distal Esophageal Spasm and Jackhammer Esophagus
Not all primary motility disorders involve nerve cell destruction. Distal esophageal spasm is an exceedingly rare condition where contractions in the lower esophagus fire too early, arriving before the normal peristaltic wave has time to travel down. Despite its reputation as a common cause of esophageal chest pain, most cases of chest pain originally attributed to spasm turn out to be caused by acid reflux or achalasia instead. The neuromuscular defect behind distal esophageal spasm remains unknown, and the most notable physical change found in affected tissue is a dramatic thickening of the esophageal muscle wall, sometimes up to 2 centimeters.
Jackhammer esophagus (hypercontractile esophagus) involves contractions that are abnormally forceful rather than mistimed. Both conditions can cause chest pain and difficulty swallowing, but they originate from different mechanical problems, one involving timing and the other involving the sheer power of muscle contractions.
Scleroderma and Connective Tissue Disease
Systemic sclerosis (scleroderma) is one of the most well-established systemic causes of esophageal dysmotility. This autoimmune condition damages small blood vessels and deposits scar tissue in multiple organs, and the esophagus is a frequent target. Progressive fibrosis replaces the smooth muscle of the esophageal wall, weakening contractions and reducing the tone of the lower esophageal sphincter. The result is both poor peristalsis and severe acid reflux, since the weakened sphincter can no longer keep stomach acid out.
Esophageal involvement is so characteristic of scleroderma that it’s built into the name of one of its subtypes: CREST syndrome, where the “E” stands for esophageal dysmotility. Raynaud phenomenon, a hallmark of scleroderma involving spasm of small blood vessels in the fingers, has also been independently associated with esophageal motility problems, suggesting that vascular damage may play a role in how the esophagus loses function.
Diabetes and Nerve Degeneration
Diabetes affects the esophagus through the same mechanism it uses to damage nerves elsewhere in the body. The prevailing theory is that chronic high blood sugar causes segmental loss of the protective coating around parasympathetic nerves in the esophageal wall, along with gradual shrinkage of the nerve fibers themselves. This is essentially the same type of nerve damage that causes numbness in the feet or slowed stomach emptying (gastroparesis) in people with long-standing diabetes.
The gastrointestinal tract is commonly affected in diabetes, and while the stomach gets most of the attention, esophageal symptoms like heartburn and difficulty swallowing can also develop. Some research suggests that diabetic patients with heartburn are more likely to have a functional nerve signaling problem rather than true acid damage, which is why standard acid-blocking medications don’t always resolve their symptoms.
Chronic Acid Reflux
The relationship between gastroesophageal reflux disease (GERD) and dysmotility runs in both directions. Poor esophageal motility allows acid to linger in the esophagus longer, worsening reflux symptoms. But chronic acid exposure itself can also impair the esophageal muscles over time, creating a cycle of worsening function. Research using pressure-measuring studies has found peristaltic dysfunction in 56% of patients with reflux symptoms but no visible damage and in 76% of those with erosive reflux disease. This suggests that motility problems and reflux frequently coexist, and that ongoing acid exposure may progressively weaken the esophagus’s ability to clear itself.
Neurological Conditions
Because swallowing depends on coordinated nerve signaling from the brain through the esophageal wall, neurological diseases can disrupt the process at several points. Stroke can weaken or discoordinate the muscles of the mouth, throat, and upper esophagus. Multiple sclerosis damages the insulating coating around nerves in the brain and spinal cord, which can slow or scramble the signals that initiate and sustain peristalsis. Parkinson’s disease affects the autonomic nervous system broadly, and esophageal dysfunction is a recognized but often overlooked feature.
Chagas disease, caused by a parasitic infection common in parts of Central and South America, destroys the same esophageal nerve cells that are lost in achalasia. The result is nearly identical: a dilated, poorly contracting esophagus with a sphincter that won’t relax. Though rare in the United States, it’s an important consideration in patients who have lived in endemic areas.
Aging and the Esophagus
The esophagus does change with age, though not as dramatically as once thought. Peristalsis is more likely to fail in older adults, meaning contractions may not travel the full length of the esophagus or may be too weak to effectively push food through. The ability to sense what’s happening inside the esophagus also declines with aging, which means older adults may not feel reflux episodes or food getting stuck until the problem is more advanced. Interestingly, the lower esophageal sphincter itself changes relatively little with age, so age-related dysmotility is primarily a problem of the esophageal body rather than the valve at the bottom.
Medications and Surgery
Certain medications can slow esophageal transit and mimic or worsen dysmotility. Anticholinergic drugs, which are found in many allergy medications, bladder medications, and some antidepressants, reduce both saliva production and the strength of esophageal contractions. Opioid pain medications slow motility throughout the entire gastrointestinal tract, including the esophagus. These drug effects are usually reversible once the medication is stopped, but they can cause significant symptoms while you’re taking them.
Surgical procedures can also create motility problems. Fundoplication, a surgery that wraps part of the stomach around the lower esophagus to treat severe reflux, can sometimes produce a condition that mimics achalasia if the wrap is too tight. In one study, patients who underwent a full (Nissen) fundoplication reported dysphagia at a rate of 27% at one year, compared to 9% in a comparison group. Chest pain while eating was also significantly more common after surgery. Some surgeons consider the complete absence of esophageal contractions a reason to avoid full fundoplication entirely, opting for a partial wrap instead to reduce the risk of post-surgical swallowing problems.
How Dysmotility Is Classified
Doctors identify the specific type of dysmotility using a test called high-resolution manometry, which involves swallowing a thin tube lined with pressure sensors. The current standard for interpreting results is the Chicago Classification version 4.0, which categorizes motility disorders based on patterns of pressure, timing, and sphincter relaxation. The latest version of this system requires testing in both lying-down and upright positions, plus provocative challenges like rapid swallowing, to reduce the chance of misdiagnosis. Results are classified as either conclusive or inconclusive depending on whether symptoms and additional testing line up with the pressure findings. This matters because abnormal pressure patterns on manometry don’t always mean the person has a clinically significant motility disorder, and overdiagnosis can lead to unnecessary treatment.